Latest round: Series A. Jeff Baxter is the CEO of VBI Vaccines, a commercial-stage biopharmaceutical company focused on developing next-generation vaccines.
Jeff Baxter is the CEO of VBI Vaccines, a commercial-stage biopharmaceutical company focused on developing next-generation vaccines for infectious diseases and immuno-oncology. He played an active role in the company's Series A financing and has led several technology acquisitions. Under his leadership, VBI Vaccines advanced two coronavirus vaccine candidates into human clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library